Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report
journal contribution
submitted on 2024-11-26, 09:39 and posted on 2024-11-26, 09:39 authored by Afra M. Elhassan, Arwa Alsaud, Mohamed A. Yassin, Mahmood Aldapt, Lubna Riaz, Firdous Ghori, Aiman Bin Ahmad, Mohammad AbdullaEssential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 103/μL, diagnosed as ET as per WHO criteria 2008; she required ICU admission and thrombocytapheresis with a favorable outcome.
Other Information
Published in: Case Reports in Oncology
License: https://creativecommons.org/licenses/by-nc/4.0/
See article on publisher's website: https://dx.doi.org/10.1159/000507651
Funding
Open Access funding provided by the Qatar National Library.
History
Language
- English
Publisher
KargerPublication Year
- 2020
License statement
This Item is licensed under the Creative Commons Attribution-NonCommercial 4.0 International LicenseInstitution affiliated with
- Hamad Medical Corporation
- National Center for Cancer Care and Research - HMC
